All of the commentary on $ILMN is utterly useless click-bait horseshit — strewn out and festooned all over the internet. As far as I can tell, growth is slowing at ILMN and the company woefully missed guidance. And as a result, the executioner is chopping off the heads of their shareholders in the after hours.
Illumina (halted) lowers Q3 sales guidance, guides Q4 sales below consensus — driven by a larger than anticipated Y/Y decline in high throughput sequencing instruments (184.85 +0.36)
Lowers Q3 rev to $607 mln (+10% Y/Y) from $625-630 mln vs $628.26 mln Capital IQ Consensus.
The shortfall in quarterly revenue was driven by a larger than anticipated year-over-year decline in high throughput sequencing instruments.
As a result, the company expects fourth quarter revenue will be flat to slightly up sequentially (from $607 mln vs. $684 mln consensus).
ILMN is one of the largest index members in the IBB — which is off by 1% in the after-hours. Something tells me that it will trade much lower tomorrow.
To put the valuation into perspective, courtesy of Exodus, ILMN was trading at a discount on a price to sales basis — compared to previous years. But, when compared to their large cap peers, the valuation is almost twice as high.
WTF 25% off in AH. Did they say the are going to buy TWTR on the fucking conference call?
Biotechs are hazardous to your health. Extra irony.
i bought this stock at 135.26, all gains have been erased.